1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bladder Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Intravesical therapy
1.2.3 Chemotherapy
1.2.4 Preservation therapy
1.3 Market by Application
1.3.1 Global Bladder Cancer Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bladder Cancer Market Perspective (2017-2028)
2.2 Bladder Cancer Growth Trends by Region
2.2.1 Bladder Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bladder Cancer Historic Market Size by Region (2017-2022)
2.2.3 Bladder Cancer Forecasted Market Size by Region (2023-2028)
2.3 Bladder Cancer Market Dynamics
2.3.1 Bladder Cancer Industry Trends
2.3.2 Bladder Cancer Market Drivers
2.3.3 Bladder Cancer Market Challenges
2.3.4 Bladder Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bladder Cancer Players by Revenue
3.1.1 Global Top Bladder Cancer Players by Revenue (2017-2022)
3.1.2 Global Bladder Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Bladder Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bladder Cancer Revenue
3.4 Global Bladder Cancer Market Concentration Ratio
3.4.1 Global Bladder Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Revenue in 2021
3.5 Bladder Cancer Key Players Head office and Area Served
3.6 Key Players Bladder Cancer Product Solution and Service
3.7 Date of Enter into Bladder Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bladder Cancer Breakdown Data by Type
4.1 Global Bladder Cancer Historic Market Size by Type (2017-2022)
4.2 Global Bladder Cancer Forecasted Market Size by Type (2023-2028)
5 Bladder Cancer Breakdown Data by Application
5.1 Global Bladder Cancer Historic Market Size by Application (2017-2022)
5.2 Global Bladder Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bladder Cancer Market Size (2017-2028)
6.2 North America Bladder Cancer Market Size by Country (2017-2022)
6.3 North America Bladder Cancer Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Bladder Cancer Market Size (2017-2028)
7.2 Europe Bladder Cancer Market Size by Country (2017-2022)
7.3 Europe Bladder Cancer Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bladder Cancer Market Size (2017-2028)
8.2 Asia-Pacific Bladder Cancer Market Size by Country (2017-2022)
8.3 Asia-Pacific Bladder Cancer Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Bladder Cancer Market Size (2017-2028)
9.2 Latin America Bladder Cancer Market Size by Country (2017-2022)
9.3 Latin America Bladder Cancer Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bladder Cancer Market Size (2017-2028)
10.2 Middle East & Africa Bladder Cancer Market Size by Country (2017-2022)
10.3 Middle East & Africa Bladder Cancer Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Bladder Cancer Introduction
11.1.4 Bristol-Myers Squibb Revenue in Bladder Cancer Business (2017-2022)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Bladder Cancer Introduction
11.2.4 Eli Lilly Revenue in Bladder Cancer Business (2017-2022)
11.2.5 Eli Lilly Recent Development
11.3 F. Hoffman-La Roche
11.3.1 F. Hoffman-La Roche Company Detail
11.3.2 F. Hoffman-La Roche Business Overview
11.3.3 F. Hoffman-La Roche Bladder Cancer Introduction
11.3.4 F. Hoffman-La Roche Revenue in Bladder Cancer Business (2017-2022)
11.3.5 F. Hoffman-La Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bladder Cancer Introduction
11.4.4 Pfizer Revenue in Bladder Cancer Business (2017-2022)
11.4.5 Pfizer Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Detail
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Bladder Cancer Introduction
11.5.4 Accord Healthcare Revenue in Bladder Cancer Business (2017-2022)
11.5.5 Accord Healthcare Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Bladder Cancer Introduction
11.6.4 AstraZeneca Revenue in Bladder Cancer Business (2017-2022)
11.6.5 AstraZeneca Recent Development
11.7 Bedford Lab
11.7.1 Bedford Lab Company Detail
11.7.2 Bedford Lab Business Overview
11.7.3 Bedford Lab Bladder Cancer Introduction
11.7.4 Bedford Lab Revenue in Bladder Cancer Business (2017-2022)
11.7.5 Bedford Lab Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Bladder Cancer Introduction
11.8.4 Merck Revenue in Bladder Cancer Business (2017-2022)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Bladder Cancer Introduction
11.9.4 Sanofi Revenue in Bladder Cancer Business (2017-2022)
11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Bladder Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Intravesical therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Preservation therapy
Table 5. Global Bladder Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Bladder Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Bladder Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Bladder Cancer Market Share by Region (2017-2022)
Table 9. Global Bladder Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Bladder Cancer Market Share by Region (2023-2028)
Table 11. Bladder Cancer Market Trends
Table 12. Bladder Cancer Market Drivers
Table 13. Bladder Cancer Market Challenges
Table 14. Bladder Cancer Market Restraints
Table 15. Global Bladder Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Bladder Cancer Market Share by Players (2017-2022)
Table 17. Global Top Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer as of 2021)
Table 18. Ranking of Global Top Bladder Cancer Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Bladder Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bladder Cancer Product Solution and Service
Table 22. Date of Enter into Bladder Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bladder Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Bladder Cancer Revenue Market Share by Type (2017-2022)
Table 26. Global Bladder Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Bladder Cancer Revenue Market Share by Type (2023-2028)
Table 28. Global Bladder Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Bladder Cancer Revenue Market Share by Application (2017-2022)
Table 30. Global Bladder Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Bladder Cancer Revenue Market Share by Application (2023-2028)
Table 32. North America Bladder Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Bladder Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Bladder Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Bladder Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Bladder Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Bladder Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Bladder Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Bladder Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Bladder Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Bladder Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 42. Bristol-Myers Squibb Company Detail
Table 43. Bristol-Myers Squibb Business Overview
Table 44. Bristol-Myers Squibb Bladder Cancer Product
Table 45. Bristol-Myers Squibb Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 46. Bristol-Myers Squibb Recent Development
Table 47. Eli Lilly Company Detail
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Bladder Cancer Product
Table 50. Eli Lilly Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 51. Eli Lilly Recent Development
Table 52. F. Hoffman-La Roche Company Detail
Table 53. F. Hoffman-La Roche Business Overview
Table 54. F. Hoffman-La Roche Bladder Cancer Product
Table 55. F. Hoffman-La Roche Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 56. F. Hoffman-La Roche Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Bladder Cancer Product
Table 60. Pfizer Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Accord Healthcare Company Detail
Table 63. Accord Healthcare Business Overview
Table 64. Accord Healthcare Bladder Cancer Product
Table 65. Accord Healthcare Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 66. Accord Healthcare Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Bladder Cancer Product
Table 70. AstraZeneca Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Bedford Lab Company Detail
Table 73. Bedford Lab Business Overview
Table 74. Bedford Lab Bladder Cancer Product
Table 75. Bedford Lab Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 76. Bedford Lab Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Bladder Cancer Product
Table 80. Merck Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Sanofi Company Detail
Table 83. Sanofi Business Overview
Table 84. Sanofi Bladder Cancer Product
Table 85. Sanofi Revenue in Bladder Cancer Business (2017-2022) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bladder Cancer Market Share by Type: 2021 VS 2028
Figure 2. Intravesical therapy Features
Figure 3. Chemotherapy Features
Figure 4. Preservation therapy Features
Figure 5. Global Bladder Cancer Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Bladder Cancer Report Years Considered
Figure 9. Global Bladder Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Bladder Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Bladder Cancer Market Share by Region: 2021 VS 2028
Figure 12. Global Bladder Cancer Market Share by Players in 2021
Figure 13. Global Top Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Bladder Cancer Revenue in 2021
Figure 15. North America Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Bladder Cancer Market Share by Country (2017-2028)
Figure 17. United States Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Bladder Cancer Market Share by Country (2017-2028)
Figure 21. Germany Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Bladder Cancer Market Share by Region (2017-2028)
Figure 29. China Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Bladder Cancer Market Share by Country (2017-2028)
Figure 37. Mexico Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Bladder Cancer Market Share by Country (2017-2028)
Figure 41. Turkey Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Bladder Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 44. Eli Lilly Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 45. F. Hoffman-La Roche Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 46. Pfizer Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 47. Accord Healthcare Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 48. AstraZeneca Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 49. Bedford Lab Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 50. Merck Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 51. Sanofi Revenue Growth Rate in Bladder Cancer Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol-Myers Squibb Eli Lilly F. Hoffman-La Roche Pfizer Accord Healthcare AstraZeneca Bedford Lab Merck Sanofi